Seelos Therapeutics Stock Shares Outstanding
Seelos Therapeutics fundamentals help investors to digest information that contributes to Seelos Therapeutics' financial success or failures. It also enables traders to predict the movement of Seelos OTC Stock. The fundamental analysis module provides a way to measure Seelos Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Seelos Therapeutics otc stock.
Seelos |
Seelos Therapeutics OTC Stock Shares Outstanding Analysis
Seelos Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Seelos Therapeutics Shares Outstanding | 581 K |
Most of Seelos Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Seelos Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Seelos Therapeutics has 581 K of shares currently outstending. This is 99.68% lower than that of the Pharmaceuticals sector and 99.46% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.9% higher than that of the company.
Seelos Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Seelos Therapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Seelos Therapeutics could also be used in its relative valuation, which is a method of valuing Seelos Therapeutics by comparing valuation metrics of similar companies.Seelos Therapeutics is currently under evaluation in shares outstanding category among its peers.
Seelos Fundamentals
Return On Equity | -5.84 | |||
Return On Asset | -2.61 | |||
Profit Margin | 2.03 % | |||
Operating Margin | (8.35) % | |||
Current Valuation | 10.45 M | |||
Shares Outstanding | 581 K | |||
Shares Owned By Insiders | 0.49 % | |||
Shares Owned By Institutions | 4.46 % | |||
Number Of Shares Shorted | 170.89 K | |||
Price To Book | 15.10 X | |||
Price To Sales | 0.37 X | |||
Revenue | 2.2 M | |||
Gross Profit | (46.65 M) | |||
EBITDA | (40.44 M) | |||
Net Income | (37.88 M) | |||
Cash And Equivalents | 41.25 M | |||
Cash Per Share | 0.39 X | |||
Total Debt | 14.23 M | |||
Debt To Equity | 0.73 % | |||
Current Ratio | 3.60 X | |||
Book Value Per Share | (135.50) X | |||
Cash Flow From Operations | (23.91 M) | |||
Short Ratio | 0.14 X | |||
Earnings Per Share | 351.04 X | |||
Target Price | 120.0 | |||
Beta | 1.85 | |||
Market Capitalization | 743.68 K | |||
Total Asset | 5.42 M | |||
Retained Earnings | (252.63 M) | |||
Working Capital | (33.52 M) | |||
Net Asset | 5.42 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in income. Note that the Seelos Therapeutics information on this page should be used as a complementary analysis to other Seelos Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Seelos OTC Stock
If you are still planning to invest in Seelos Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Seelos Therapeutics' history and understand the potential risks before investing.
Global Correlations Find global opportunities by holding instruments from different markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |